InvestorsHub Logo
Followers 128
Posts 2150
Boards Moderated 1
Alias Born 12/27/2007

Re: kei post# 5795

Tuesday, 07/18/2017 3:51:23 PM

Tuesday, July 18, 2017 3:51:23 PM

Post# of 8449
i think this time they are on track with the support by parexel .


"The stock’s most recent catalyst was its announcement that it has begun the process of digitizing its New Drug Application (NDA) for KIT-302, its lead drug candidate, through Parexel International Corporation, a clinical research organization, which has been engaged by Kitov for the preparation of the NDA into the standard, accepted electronic format of the U.S. Food and Drug Administration (FDA)."